Phase 3 Attention Clinical Trials
7 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–7 of 7 trials
Recruiting
Phase 2Phase 3
A Trial to Evaluate the Efficacy and Safety of EB-1020 in Pediatric Patients With ADHD
Attention Deficit Hyperactivity Disorder (ADHD)
Otsuka Pharmaceutical Co., Ltd.315 enrolled1 locationNCT07086313
Recruiting
Phase 3
A Long-term Trial of EB-1020 in Pediatric Patients With ADHD
Attention Deficit Hyperactivity Disorder (ADHD)
Otsuka Pharmaceutical Co., Ltd.180 enrolled1 locationNCT07087327
Recruiting
Phase 3
A Long-term Trial of EB-1020 in Adult Patients With ADHD
Attention Deficit Hyperactivity Disorder (ADHD)
Otsuka Pharmaceutical Co., Ltd.180 enrolled1 locationNCT06926829
Recruiting
Phase 2Phase 3
Evaluation of the Efficacy and Safety of EB-1020 in Adult ADHD Patients
Attention Deficit Hyperactivity Disorder (ADHD)
Otsuka Pharmaceutical Co., Ltd.630 enrolled1 locationNCT06931080
Recruiting
Phase 3
Clinical Efficacy and Long Term Effects of Transcranial Direct Current Stimulation (tDCS) in Children With Attention Deficit/Hyperactivity Disorder (ADHD)
Attention Deficit Hyperactivity DisorderTranscranial Direct Current Stimulation
Centre Hospitalier Universitaire, Amiens150 enrolled1 locationNCT04704687
Completed
Phase 3Phase 4
Omega-3s, learning and behaviour in primary school children
BehaviourQuality of LifeAttention+1 more
Natalie Parletta120 enrolled1 locationACTRN12612000962831
Completed
Phase 3
Imaging the influence and interaction of genes and stimulant medication on attention in Attention Deficit Hyperactivity Disorder (ADHD).
Attention Deficit Hyperactivity Disorder (ADHD)
Dr. Tim Silk60 enrolled1 locationACTRN12610000652077